India Glycols Limited

NSE:INDIAGLYCO.NS

1162.6 (INR) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 9,686.49,261.49,042.27,7466,890.16,193.45,5376,697.68,080.65,874.2727,950.57,801.36,506.72,365.2178,975.47,285.13,856.28,409.3798,623.98,492.68,670.28,058.4077,653.89,509.87,646.7
Cost of Revenue 7,748.17,639.86,175.75,801.14,928.13,238.53,026.14,252.35,306.24,091.8085,671.95,392.34,525.52,988.0576,103.64,450.21,882.77,014.8385,825.65,332.35,694.26,687.5224,343.76,052.44,529.7
Gross Profit 1,938.31,621.62,866.51,944.91,9622,954.92,510.92,445.32,774.41,782.4642,278.62,4091,981.2-622.842,871.82,834.91,973.51,394.5412,798.33,160.32,9761,370.8853,310.13,457.43,117
Gross Profit Ratio 0.20.1750.3170.2510.2850.4770.4530.3650.3430.3030.2870.3090.304-0.2630.320.3890.5120.1660.3240.3720.3430.170.4320.3640.408
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 0000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000
SG&A 958.4836.2781.7758228.1703.8649.1665191.71,520.363241.7250.7629.8588.3295.8284253147.657282.4288.9270.5394.992247.9249.1258.7
Other Expenses 046.545.5107.35844.769.962.661.7-160.76570.283.913.336.53214.622.214.5-51.03531.632.5-36.1912.227.17
Operating Expenses 958.4836.22,106.31,2651,167.22,2922,033.81,981.42,362.61,065.4431,933.51,944.31,631.8-964.4732,1382,176.91,634.1384.4992,105.72,223.32,064.4267.8262,453.92,500.92,191.6
Operating Income 979.9785.4853791.5794.8720.7523.5556.7411.8712.63345.1464.7349.4341.633733.8658339.41,010.042692.6937911.61,103.059856.2956.5925.4
Operating Income Ratio 0.1010.0850.0940.1020.1150.1160.0950.0830.0510.1210.0430.060.0540.1440.0820.090.0880.120.080.110.1050.1370.1120.1010.121
Total Other Income Expenses Net -223.4-229.353-221.3-178.9-157.6-264.23855.5-149.7-65-398.812-31.74.52,239.90.543-204.8-188.5-181.3-271.006-344.7-367.7-367.12,138.194-372.3-335-324.1
Income Before Tax 756.5505.6538.9501637.2456.4532.6314.2346.8318.209313.4469.22,589.3342.176431.8368.162.7277.394347.9569.3544.5424.494483.9621.5601.3
Income Before Tax Ratio 0.0780.0550.060.0650.0920.0740.0960.0470.0430.0540.0390.060.3980.1450.0480.0510.0160.0330.040.0670.0630.0530.0630.0650.079
Income Tax Expense 152.7133.9122.6120.9125.85832.378.470.9-352.63673.396.4577.2-143.541133.6102.620.198.43782209.6202.5162.653185.3232.4224.7
Net Income 603.8422.1416.3380.1511.4403.244307.3250.1290.2670.81240.1372.82,114.8709.771298.2265.542.6178.957265.9359.7342261.841298.6389.1376.6
Net Income Ratio 0.0620.0460.0460.0490.0740.0650.0550.0370.0360.1140.030.0480.3250.30.0330.0360.0110.0210.0310.0420.0390.0320.0390.0410.049
EPS 19.513.6313.4512.2816.5213.029.937.629.3721.677.7512.0468.3122.99.638.581.385.788.5911.6211.058.469.6412.5712.16
EPS Diluted 19.513.6313.4512.2816.5213.029.937.628.9121.677.7512.0468.3122.99.638.581.385.788.5911.6211.058.469.6412.5712.16
EBITDA 1,283.61,045.81,068.11,062.41,058.11,004.81,042.7741687658.8615.3745.22,961.5968.6962.2888.2564600.569904.11,1911,133.8794.4371,044.31,169.21,120.8
EBITDA Ratio 0.1330.1130.1230.1380.1620.1640.1330.1150.0970.1340.0860.1070.0870.1480.1070.1220.1450.0770.1040.140.130.0960.1360.1230.147